GlaxoSmithKline plc
Explore GlaxoSmithKline plc
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
GlaxoSmithKline plc
Explore GlaxoSmithKline plc
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$40.1B
▲ 1.5% vs FY2023 ($39.5B)
Net Income: $6.6B
Source: Annual report / company filing
GlaxoSmithKline plc reported $40.1B in revenue for fiscal year 2024. This represents a growth of 1.5% compared to the 2023 figure of $39.5B. In 2025, revenue increased to $41.5B.
Sales edged up 1.5% year over year as gains in Specialty Medicines and Trelegy Ellipta offset the 74% Arexvy collapse tied to US CDC ACIP guidance changes.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.